Literature DB >> 17682466

[A case of secondary pulmonary cryptococcosis with pleural effusion involving type 1 allergy].

Takahito Nei1, Tatsuji Enomoto, Tetsu Sakamoto, Akiko Shingu, Shinji Abe, Jiro Usuki, Arata Azuma, Shoji Kudoh, Masashi Kawamoto.   

Abstract

A 69-year-old man who had been followed for pneumoconiosis complained of dyspnea with effort. He was hospitalized because chest roentogenography showed pleural effusion. Further examination of this pleural effusion revealed an eosinophilic cell population and with a varied appearance. First, we suspected tuberculous pleuritis from the characteristics of the pleural effusion, but we could not demonstrate the existence of any acid-fast bacilli. During diagnostic studies, the patient's respiratory status gradually worsened, making it impossible to obtain essential findings. We initiated steroid administration as an antidote to progressive respiratory failure, and carried out bronchoscopy; As a result, we diagnosed secondary pulmonary cryptococcosis from bronchoalveolar lavarge and transbronchial lung biopsy. Pulmonary cryptococcosis with pleural effusion is rare, and this may be the first report of a case involving a type 1 allergy. We speculate that immunological dysfunction contributed to disease progression in this case.

Entities:  

Mesh:

Year:  2007        PMID: 17682466

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  2 in total

1.  Occult pleural cryptococcosis in an immunocompromised patient.

Authors:  S K Kamminga; C Boer; A A Rijkeboer; M A Paul; A Vonk Noordegraaf; R J Strack van Schijndel
Journal:  Intensive Care Med       Date:  2008-11-01       Impact factor: 17.440

2.  Cryptococcal Pleuritis Presenting with Lymphocyte-predominant and High Levels of Adenosine Deaminase in Pleural Effusions Coincident with Pulmonary Tuberculosis.

Authors:  Yoshitomo Kushima; Hidenori Takizawa; Yasutaka Machida; Takafumi Umetsu; Naoya Ikeda; Masaaki Miyoshi; Kazuyuki Chibana; Yasuo Shimizu; Akihiro Takemasa; Yoshiki Ishii
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.